Market Overview

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Receptos, Inc. Concerning its Proposed Sale to Celgene Corporation


The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Receptos, Inc. (NASDAQ: RCPT) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Receptos to maximize shareholder value before agreeing to be acquired by Celgene Corporation (NASDAQ: CELG).

If you would like to join the action, go to the firm's website at or contact Phillip Kim or Kevin Chan toll-free at 866-767-3653 or via e-mail at or There is no cost or obligation to you.

Under the terms of the proposed transaction, shareholders will receive $232.00 in cash for each share of Receptos stock they own. The proposed transaction is valued at approximately $7.2 billion. The investigation relates to whether the proposal is fair to the public shareholders of Receptos and whether Receptos' Board breached its fiduciary duties in connection with the proposed sale.

If you currently own shares of Receptos, Inc. and wish to obtain additional information, please visit the firm's website at You may also contact Phillip Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at or

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

The Rosen Law Firm, P.A.
Phillip Kim, Esq.
Kevin Chan, Esq.
Laurence Rosen, Esq.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: 1-866-767-3653
Fax: (212) 202-3827

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at